Jun 19, 2009
1:500
For every 500 shares held, investors received 1.
The split itself did not change the total investment value.
Bio-Genex Laboratories, Inc. (BGNX) trades on the Other OTC in the Medical - Diagnostics & Research industry.
Bio-Genex Laboratories, Inc. company overviewThe latest split shown was on June 19, 2009. It was a 1-for-500 reverse split, so shareholders received 1 share for every 500 they held.
This history records 2 splits between March 16, 2007 and June 19, 2009.
Already premium? Sign in